Richard Stryker
- Infectious Diseases top 2%
- Virology top 1%
- Epidemiology
- Emergency Medicine top 5%
- Hepatology top 5%
- Co-authors
- Nancy RuízDaniel J. SkiestSchlomo StaszewskiAnita RachlisKaren T. TashimaDominic LabriolaJavier O Morales-RamirezDouglas J. Manion
- Topics
- HIV Research and Treatment (5 papers)HIV/AIDS drug development and treatment (5 papers)HIV/AIDS Research and Interventions (4 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Richard Stryker
7 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 68
- Infectious Diseases 902
- Virology 766
- Epidemiology 217
- Emergency Medicine 207
- Hepatology 150
Countries citing papers authored by Richard Stryker
This map shows the geographic impact of Richard Stryker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Stryker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Stryker more than expected).
Fields of papers citing papers by Richard Stryker
This network shows the impact of papers produced by Richard Stryker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Stryker. The network helps show where Richard Stryker may publish in the future.
Co-authorship network of co-authors of Richard Stryker
This figure shows the co-authorship network connecting the top 25 collaborators of Richard Stryker. A scholar is included among the top collaborators of Richard Stryker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Stryker. Richard Stryker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 122 | |
| 2 | 13 | |
| 3 | 119 | |
| 4 | Kaletra (Lopinavir/ritonavir) Therapy in Single Protease Inhibitor Experienced Patients: 144-Week Follow-up | 7 |
| 5 | 16 | |
| 6 | Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adultsbreakdown → | 788 |
| 7 | 18 |
About Richard Stryker
Richard Stryker is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 7 papers that have together received 1.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (5 papers) and HIV/AIDS Research and Interventions (4 papers). The work is most often cited by research in Virology (766 citations), Infectious Diseases (902 citations) and Emergency Medicine (207 citations). Richard Stryker has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Nancy Ruíz, Daniel J. Skiest, Schlomo Staszewski, Anita Rachlis, Karen T. Tashima, Dominic Labriola, Javier O Morales-Ramirez, Douglas J. Manion, James Stanford and Philip C. Johnson. Their work appears in journals such as New England Journal of Medicine, The Journal of Infectious Diseases and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.